Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Maeva Zysman (Vincennes, France), Maeva Zysman, Pierre Regis Burgel, Jean Louis Paillasseur, Pascal Chanez, Denis Caillaud, Roger Escamilla, Isabelle Court Fortune, Pascal Nesme Meyer, Graziella Brinchault Rabin, Gaetan Deslee, Thierry Perez, Christophe Pinet, Nicolas Roche. Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD. Eur Respir J 2016; 48: Suppl. 60, 4614

Member's Comments

No comment yet.

Related content which might interest you: Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Distribution of blood eosinophil in COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 LATE-BREAKING ABSTRACT: Stability of blood eosinophil count in COPD patients in the UK clinical practice research datalink Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Correlation between red cell distribution width and disease severity and mortality in COPD patients Source: International Congress 2014 – COPD exacerbations Year: 2014 Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study Source: International Congress 2016 – Systemic biomarkers Year: 2016 Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014 Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Haemoglobin level and its clinical impact in a cohort of patients with COPD Source: Eur Respir J 2007; 29: 923-929 Year: 2007 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 The relationship between blood eosinophils and bacterial load in COPD patients Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016